Sigilon Therapeutics GAAP EPS of -$0.27 beats by $0.15, revenue of $4.25M beats by $1.75M
Sigilon Therapeutics GAAP EPS of -$0.27 beats by $0.15, revenue of $4.25M beats by $1.75M (NASDAQ:SGTX)
Sigilon Therapeutics GAAP EPS of -$0.27 beats by $0.15, revenue of $4.25M beats by $1.75M